Durie-Salmon Staging (Multiple Myeloma)
Durie-Salmon Staging (Multiple Myeloma) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the Durie-Salmon Staging (Multiple Myeloma) → Runs in your browser. No signup, no tracking.
What this is
Durie-Salmon Staging (Multiple Myeloma) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. Durie-Salmon Staging (Multiple Myeloma) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Durie BGM, Salmon SE. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36(3):842-854. Read the source ↗
Worked example: Durie-Salmon stage IIIA.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.